AKT1 and lung carcinoma: FBLN3 suppresses tumor invasiveness through inhibition of the MAPK pathway in lung cancer [44], and it enhances tumor cell growth and induces epithelial–mesenchymal transition (EMT) by activation of the AKT/mTOR pathway in cervical cancer [45].